Unipharma
Board
3 directors, last change in 2025Director
appointed by deed of 22-01-2024
6-year term from 2024
listed in the 2025 annual accounts, filed on 27-08-2026
Director
appointed by deed of 22-01-2024
6-year term from 2024
also on the board of 1 other company
listed in the 2025 annual accounts, filed on 27-08-2026
Director
appointed by deed of 22-01-2024
6-year term from 2024
also on the board of 2 other companies
listed in the 2025 annual accounts, filed on 27-08-2026
- Signing authorityThe articles say who may bind the company, for example by signing a contract.
- “Article 16. Pouvoirs de l’organe d’administration Sans préjudice du pouvoir de représentation général de l’organe d’administration comme…”deed of 22-01-2024
Mandates through the years
4 names, the dashed line is todayBoardEarlierRest of the termmandate already running before its first mention
Mandates as a list
- GAYE Jean-Charles
- Director, since before 31-12-2021
- MONIN François Joseph Michel Christian
- Director, since before 31-12-2021
- STAQUET Laurent Victor Edouard
- Director, since before 31-12-2021
- Anne Coppe
- Director, until 19-03-2025
Control
Shareholders
MANET Maurice Joseph, DEHAUT Jacques Michel Robert, MONIN François Joseph Michel Christian
and 2 others
This company
Unipharma
Equity €798,860
Profit €91,588 in 2025
Capital
- Contribution
- €74,367.60
- Source
- 2025 annual accounts
Articles of association
deed of 22-01-2024 (in French)- Board ruleThese rules set how the board is made up, meets and takes decisions.
- At least 3 directors
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- Last Thursday of May at 18:00
Shareholders
Stated in the deed
deed of 22-01-2024 ↗
- MANET Maurice Joseph 6 shares
- DEHAUT Jacques Michel Robert 6 shares
- MONIN François Joseph Michel Christian 42 shares
- STAQUET Laurent Victor Edouard Ghislain 36 shares
- GAYE Jean-Charles Philippe Rémi 6 shares